TrialAllergy2025

SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.

Graham Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.